- Home
- SXTC
SXTC
China SXT Pharmaceuticals Inc.
as 04-18-2025 1:43pm EST
| Founded: | 2005 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2019 |
| Target Price: | N/A | AVG Volume (30 days): | 2.6M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 20.77 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.30 - $5.70 | Next Earning Date: | 01-01-0001 |
| Revenue: | $1,818,404 | Revenue Growth: | 6.78% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest China SXT Pharmaceuticals Inc. News
SXTC Breaking Stock News: Dive into SXTC Ticker-Specific Updates for Smart Investing
MT Newswires
a month ago
China Sxt Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Requirement
GlobeNewswire
a month ago
China SXT Pharmaceuticals Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency
GlobeNewswire
2 months ago
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
GlobeNewswire
6 months ago
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
The Telegraph
10 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Motley Fool
10 months ago
4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
AFP
10 months ago
Seoul resumes loudspeaker propaganda against North
Simply Wall St.
10 months ago
Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss
Compare SXTC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SXTC China SXT Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.